Last reviewed · How we verify
Methaderm (dexamethasone dipropionate)
Methaderm (generic name: dexamethasone dipropionate) is a Corticosteroid drug. It is currently in unknown development.
Methaderm works by binding to glucocorticoid receptors in the body, triggering a response that reduces inflammation and suppresses the immune system.
Methaderm (dexamethasone dipropionate) is a corticosteroid small molecule medication. It is used to treat various inflammatory conditions, although specific approved indications are not provided. As a corticosteroid, Methaderm works by mimicking the effects of cortisol in the body, reducing inflammation and suppressing the immune system. The commercial status of Methaderm is unknown, and key safety considerations include potential side effects such as increased risk of infections and osteoporosis. Further information on its pharmacokinetics and commercial status is required.
At a glance
| Generic name | dexamethasone dipropionate |
|---|---|
| Drug class | Corticosteroid |
| Therapeutic area | Immunology |
| Phase | unknown |
Mechanism of action
Imagine your body's immune system as a fire alarm that sounds when it detects an intruder. Corticosteroids like Methaderm are like a fire alarm silencer that reduces the alarm's sensitivity, allowing the body to reduce its inflammatory response and 'put out the fire'. This can help alleviate symptoms of conditions like arthritis or asthma.
Approved indications
Common side effects
Key clinical trials
- Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis (PHASE3)
- Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells (PHASE2)
- Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methaderm CI brief — competitive landscape report
- Methaderm updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Methaderm
What is Methaderm?
How does Methaderm work?
What is the generic name of Methaderm?
What drug class is Methaderm in?
What development phase is Methaderm in?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Immunology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing